Virtual Medicinal Product (VMP) - Nivolumab 240mg/20ml / Relatlimab 80mg/20ml solution for infusion vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Nivolumab 240mg/20ml / Relatlimab 80mg/20ml solution for infusion vials | Start Date 06-03-2024 | End Date |
| Abbreviated Name | Abbreviated Name Nivolumab 240mg/20ml / Relatlimab 80mg/20ml inf vials | Start Date 06-03-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 20.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- Other
Codes
- ATC Code
- L01FY02
- BNF Codes
-
- BNF code 08010600
| Code | Start Date | End Date |
|---|---|---|
| 42683911000001101 | 06-03-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Nivolumab | Based on Ingredient Substance | 12 mg | 1 ml | |
| Relatlimab | Based on Ingredient Substance | 4 mg | 1 ml |
Name
Nivolumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
12.0
Strength and UOM (Dmr)
1.0
Name
Relatlimab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
4.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMNivolumab + Relatlimab
-
VMP(Current) Nivolumab 240mg/20ml / Relatlimab 80...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |